Ownership history in RENAISSANCE TECHNOLOGIES LLC · 23 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in LANTERN PHARMA INC (LTRN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 110,400 | +10,300 | +10.3% | 0.00% | $335K | $3.03 |
| 2025 Q3 | ADDED | 100,100 | +9,500 | +10.5% | 0.00% | $435K | $4.35 |
| 2025 Q2 | ADDED | 90,600 | +1,800 | +2.0% | 0.00% | $286K | $3.16 |
| 2025 Q1 | ADDED | 88,800 | +1,500 | +1.7% | 0.00% | $314K | $3.54 |
| 2024 Q4 | ADDED | 87,300 | +3,300 | +3.9% | 0.00% | $278K | $3.19 |
| 2024 Q3 | ADDED | 84,000 | +2,200 | +2.7% | 0.00% | $308K | $3.67 |
| 2024 Q2 | ADDED | 81,800 | +16,100 | +24.5% | 0.00% | $382K | $4.67 |
| 2024 Q1 | ADDED | 65,700 | +21,900 | +50.0% | 0.00% | $578K | $8.80 |
| 2023 Q4 | ADDED | 43,800 | +5,700 | +15.0% | 0.00% | $187K | $4.28 |
| 2023 Q3 | REDUCED | 38,100 | -6,800 | -15.1% | 0.00% | $130K | $3.41 |
As of 2025 Q4 — sorted by position size